-
2023-505242-25-00
4
2024-11-05
High-Risk Monoclonal Gammopathy of Undetermined Significance;
Non-Hig
-
2024-512194-27-01
6
2024-10-21
Patients receiving oral anticoagulant therapy who are scheduled for el
-
2023-507809-34-00
9
2024-08-07
Relapsed or Refractory Systemic Light Chain Amyloidosis
-
2023-504340-34-01
6
2024-01-11
Coronary artery disease
-
2023-510541-25-00
1
2023-10-09
Relapsed/Refractory B-cell Malignancies
-
2024-510959-35-00
4
2023-09-07
Parkinson's disease
-
2024-518998-33-00
5
2025-07-23
Ulcerative Colitis
-
2024-513970-23-00
4
2025-02-27
Previously Untreated Chronic Lymphocytic Leukemia
-
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
-
2022-502446-27-00
5
2024-02-26
Relapsed or Refractory Myeloma
-
2022-501396-62-00
5
2023-12-12
Relapsed Refractory Multiple Myeloma
-
2023-504273-21-00
4
2023-10-31
Multiple Myeloma
-
2022-500290-14-01
4
2023-05-11
Colitis ulcerative
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2024-517008-12-00
5
2022-10-14
Newly-diagnosed multiple myeloma (NDMM)
-
2024-518304-53-00
5
2022-02-02
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2023-509372-41-00
5
2022-01-30
Multiple Sclerosis
-
2023-503441-55-00
4
2021-10-14
Relapsed/Refractory Multiple Myeloma
-
2024-516039-28-00
6
2021-09-28
Spontaneous Coronary Artery Dissection.
-
2023-504684-16-00
5
2021-06-05
follicular lymphoma (FL) and marginal zone lymphoma (MZL)
-
2022-503072-84-00
5
2021-02-13
stage IIIa cardiac AL amyloidosis
-
2022-503073-11-00
5
2021-02-13
Stage IIIb cardiac AL amyloidosis
-
2023-509358-72-00
5
2020-11-23
Diffuse large B-cell lymphoma
-
2023-506877-37-00
5
2020-09-28
Relapsed/Refractory Multiple Myeloma